spironolactone has been researched along with atrial natriuretic factor in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (10.34) | 18.7374 |
1990's | 6 (20.69) | 18.2507 |
2000's | 14 (48.28) | 29.6817 |
2010's | 6 (20.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donker, AJ; Hackeng, WH; Meuwissen, SG; van Vliet, AA | 1 |
Currie, MG; Lanier-Smith, KL | 1 |
Abraham, WT; Dürr, JA; Hensen, J; Schrier, RW | 1 |
Fujii, J; Ishibashi, M; Nakaoka, H; Sekihara, H; Takaku, F; Yamaji, T | 1 |
Ichikawa, S; Kato, T; Kogure, M; Murata, K; Nakamura, T; Sakamaki, T; Sato, K; Tajima, Y | 1 |
Chen, JH; Hwang, SJ; Lai, YH; Tsai, JH | 1 |
D'Avanzo, L; Gazzotti, RM; Ghielmi, S; Poiesi, C; Usberti, M | 1 |
Villarreal, D; Weber, KT | 1 |
Fevery, J; Lijnen, P; Nevens, F; VanBilloen, H | 1 |
Delcayre, C; Desopper, C; Escoubet, B; Heymes, C; Oubénaïssa, A; Robert, V; Silvestre, JS; Swynghedauw, B | 1 |
Copolov, D; Huang, W; Lee, D; Lim, AT; Wang, L | 1 |
Barthelmebs, M; De Jong, W; De Kloet, ER; Grima, M; Imbs, JL; Rahmouni, K; Sibug, RM | 1 |
Hayashi, Y; Hiraishi, T; Kobayashi, Y; Ohtani, M | 1 |
Ahn, S; Duprez, D; Galanti, L; Gurné, O; Ketelslegers, JM; Robert, A; Rousseau, MF; Van Mieghem, W | 1 |
Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B | 1 |
Fujii, M; Hayashi, M; Ishii, C; Maeda, K; Matsumoto, T; Ohnishi, M; Takayama, T; Tsutamoto, T; Tsutsui, T; Wada, A; Yamamoto, T | 1 |
Bauer, JA; Ghosh, S; Holycross, BJ; Kambara, A; Kwiatkowski, P; McCune, SA; Schanbacher, B; Wung, P | 1 |
Akioka, K; Iwao, H; Izumi, Y; Kim, S; Matsumoto, R; Nakamura, Y; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
Chen, YF; Feng, JA; Franco, V; Hasan, E; Li, P; Oparil, S; Perry, GJ; Wang, D | 1 |
de Resende, MM; Greene, AS; Kriegel, AJ | 1 |
Boluyt, MO; Cirrincione, G; Hwang, HS; McCormick, RJ; Thomas, DP | 1 |
Imagawa, K; Kawata, H; Kishimoto, I; Nakao, K; Naya, N; Saito, Y; Somekawa, S; Takeda, Y; Uemura, S; Zhang, Q | 1 |
Hayashi, T; Kimura, S; Kitada, K; Kitaura, Y; Kobayashi, K; Kurumazuka, D; Matsuda, H; Matsumoto, C; Matsumura, Y; Mori, T; Shirakawa, H | 1 |
Fujita, M; Hasegawa, K; Kawamura, T; Kita, T; Morimoto, T; Shimatsu, A; Sunagawa, Y; Takaya, T; Wada, H; Yoshida, Y | 1 |
Braga-Sobrinho, C; Leite-Dellova, DC; Mello-Aires, M | 1 |
Bonomo, C; Campos, DH; Cezar, MD; Cicogna, AC; Damatto, RL; Gimenes, R; Guizoni, DM; Lima, AR; Martinez, PF; Okoshi, K; Okoshi, MP; Pagan, LU; Rosa, CM | 1 |
Baba, HA; Frantz, S; Gaßner, B; Kuhn, M; Nakagawa, H; Nikolaev, VO; Oberwinkler, H; Saito, Y; Umbenhauer, S; Wagner, H | 1 |
Amancio, Gde C; Araujo, CM; de Assis, LV; Hermidorff, MM; Isoldi, MC; Lemos, Dda S; Silva, ME | 1 |
Asensio-López, MC; Caballero, L; Fernández-Del Palacio, MJ; Gimeno-Blanes, JR; Lax, A; Navarro-Peñalver, M; Pascual-Figal, DA; Pérez-Martínez, MT; Sánchez-Más, J | 1 |
1 review(s) available for spironolactone and atrial natriuretic factor
Article | Year |
---|---|
Role of aldosterone in congestive heart failure.
Topics: Aldosterone; Atrial Natriuretic Factor; Heart Failure; Humans; Renin-Angiotensin System; Spironolactone | 1993 |
2 trial(s) available for spironolactone and atrial natriuretic factor
Article | Year |
---|---|
The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Ascites; Atrial Natriuretic Factor; Blood Pressure; Diuretics; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasma Volume; Propranolol; Renin; Reproducibility of Results; Spironolactone | 1996 |
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
Topics: Aged; Aged, 80 and over; Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Spironolactone; Treatment Outcome | 2002 |
26 other study(ies) available for spironolactone and atrial natriuretic factor
Article | Year |
---|---|
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Renin; Sodium; Spironolactone | 1992 |
Glucocorticoid regulation of atrial natriuretic peptide receptors on cultured endothelial cells.
Topics: Animals; Atrial Natriuretic Factor; Autoradiography; Binding, Competitive; Cells, Cultured; Cross-Linking Reagents; Cyclic GMP; Dexamethasone; Endothelium, Vascular; Glucocorticoids; Mifepristone; Peptide Fragments; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Spironolactone | 1991 |
Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
Topics: Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Potassium; Renin-Angiotensin System; Sodium; Sodium, Dietary; Spironolactone | 1991 |
Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension.
Topics: Adult; Atrial Natriuretic Factor; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Spironolactone | 1986 |
Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Desoxycorticosterone; Humans; Hydrocortisone; Hyperaldosteronism; Middle Aged; Mineralocorticoids; Natriuresis; Potassium; Renin; Spironolactone | 1987 |
Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Atrial Natriuretic Factor; Female; Furosemide; Humans; Hyperaldosteronism; Hyperplasia; Isotonic Solutions; Male; Middle Aged; Radioimmunoassay; Sodium Chloride; Spironolactone | 1988 |
Considerations on the sodium retention in nephrotic syndrome.
Topics: Adolescent; Adult; Atrial Natriuretic Factor; Blood Volume; Diuretics; Humans; Kidney; Lithium; Middle Aged; Nephrotic Syndrome; Peptide Fragments; Renin-Angiotensin System; Serum Albumin; Sodium; Sodium, Dietary; Spironolactone | 1995 |
Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids.
Topics: Adrenalectomy; Age Factors; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blotting, Western; Collagen; Glucocorticoids; Heart; Hypertension; Kidney; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Steroid; RNA, Complementary; Sodium Chloride; Spironolactone; Time Factors | 2000 |
Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neurons.
Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Desoxycorticosterone; Dexamethasone; Dopamine; Down-Regulation; Gene Expression Regulation; Glucocorticoids; Hypothalamus; Mifepristone; Neurons; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Spironolactone; Transcription, Genetic | 2000 |
Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Topics: Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Brain; Chlorides; Desoxycorticosterone; Diuresis; Hypertension; Injections, Intraventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; Potassium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger; Sodium; Sodium Chloride, Dietary; Spironolactone; Time Factors; Transcription, Genetic | 2002 |
Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide.
Topics: Administration, Oral; Atrial Natriuretic Factor; Cardiopulmonary Bypass; Female; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Mitral Valve Stenosis; Postoperative Care; Spironolactone; Tricuspid Valve Insufficiency | 2002 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome | 2003 |
Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patients; Spironolactone | 2003 |
Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure.
Topics: Administration, Oral; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Diuresis; Drug Therapy, Combination; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Hypertrophy; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Spironolactone; Time Factors; Ultrasonography | 2003 |
Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
Topics: Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Collagen Type I; Collagen Type III; Drug Synergism; Echocardiography; Gene Expression Profiling; Heart; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Ventricular Function, Left; Ventricular Remodeling | 2004 |
Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Eplerenone; Heart; Hypertrophy; Male; Mice; Mice, Knockout; Myocardium; Spironolactone; Ventricular Remodeling | 2006 |
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Injections, Subcutaneous; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred Strains; Spironolactone; Ventricular Function, Left; Weight Loss | 2006 |
Aldosterone antagonism fails to attenuate age-associated left ventricular fibrosis.
Topics: Aging; Aldosterone; Animals; Atrial Natriuretic Factor; Collagen; Collagen Type III; Female; Fibrosis; Gene Expression; Heart Ventricles; Mineralocorticoid Receptor Antagonists; Myocardium; Myosin Heavy Chains; Rats; Rats, Inbred F344; RNA, Messenger; Spironolactone; Tissue Distribution; Ventricular Myosins | 2007 |
The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A.
Topics: Animals; Atrial Natriuretic Factor; Eplerenone; Guanylate Cyclase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Spironolactone; Systole; Ventricular Remodeling | 2008 |
Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Body Weight; Cell Size; Contraindications; Diet, Sodium-Restricted; Endomyocardial Fibrosis; Heart; Heart Failure; Hemodynamics; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transforming Growth Factor beta; Tyrosine; Ventricular Remodeling | 2009 |
Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Chlorocebus aethiops; COS Cells; Disease Models, Animal; E1A-Associated p300 Protein; GATA4 Transcription Factor; Hypertrophy; Mice; Myocytes, Cardiac; NIH 3T3 Cells; Phenylephrine; Rats; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transfection | 2010 |
Action of ANP on the nongenomic dose-dependent biphasic effect of aldosterone on NHE1 in proximal S3 segment.
Topics: Acid-Base Equilibrium; Aldosterone; Ammonium Chloride; Animals; Atrial Natriuretic Factor; Calcium Signaling; Chelating Agents; Hydrogen-Ion Concentration; In Vitro Techniques; Kidney Tubules, Proximal; Kinetics; Male; Microdissection; Mifepristone; Mineralocorticoid Receptor Antagonists; Osmolar Concentration; Rats; Rats, Wistar; Receptors, Glucocorticoid; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Spironolactone | 2012 |
Aldosterone blockade reduces mortality without changing cardiac remodeling in spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Electrocardiography; Gene Expression Regulation; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Papillary Muscles; Rats; Rats, Inbred SHR; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spironolactone; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Topics: Animals; Atrial Natriuretic Factor; Blotting, Western; Cardiomyopathy, Dilated; Connective Tissue Growth Factor; Disease Models, Animal; DNA; Eplerenone; Gene Expression Regulation; HEK293 Cells; Humans; Immunohistochemistry; Mice; Mice, Knockout; Microscopy, Confocal; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Spironolactone; Ventricular Remodeling | 2014 |
Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?
Topics: A Kinase Anchor Proteins; Aldosterone; Animals; Atrial Natriuretic Factor; Cyclic AMP; Egtazic Acid; Heart Failure; Humans; Hypertrophy; Mitogen-Activated Protein Kinase 7; Myocytes, Cardiac; Phosphorylation; Primary Cell Culture; Protein Kinase C; Rats; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone | 2016 |
The TBX1 Transcription Factor in Cardiac Remodeling After Myocardial Infarction.
Topics: Actinin; Animals; Atrial Natriuretic Factor; Blotting, Western; Eplerenone; Fibrosis; Gene Expression Regulation, Developmental; Heart; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spironolactone; T-Box Domain Proteins; Ventricular Remodeling | 2016 |